William Greenhalf

William Greenhalf

UNVERIFIED PROFILE

Are you William Greenhalf?   Register this Author

Register author
William Greenhalf

William Greenhalf

Publications by authors named "William Greenhalf"

Are you William Greenhalf?   Register this Author

69Publications

2068Reads

12Profile Views

Natural history of SPINK1 germline mutation related-pancreatitis.

EBioMedicine 2019 Oct 15;48:581-591. Epub 2019 Oct 15.

Department of Gastroenterology and Pancreatology, Beaujon Hospital, APHP, Clichy, and Paris-Diderot University, Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ebiom.2019.09.032DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6838417PMC
October 2019

Pancreas-specific plasma amylase for assessment and diagnosis of chronic pancreatitis: New insights on an old topic.

United European Gastroenterol J 2019 08 16;7(7):955-964. Epub 2019 Apr 16.

Centre for Pancreatic Diseases, Department of Gastroenterology and Hepatology, Aalborg University Hospital, Aalborg, Denmark.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2050640619846011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683646PMC
August 2019

Increased plasma levels of galectin-1 in pancreatic cancer: potential use as biomarker.

Oncotarget 2018 Aug 31;9(68):32984-32996. Epub 2018 Aug 31.

Cancer Research Program, IMIM, Hospital del Mar Medical Research Institute, Unidad Asociade CSIC, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.26034DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6152472PMC
August 2018

Therapeutic developments in pancreatic cancer: current and future perspectives.

Nat Rev Gastroenterol Hepatol 2018 06;15(6):333-348

Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41575-018-0005-xDOI Listing
June 2018

Designing a bio-inspired biomimetic in vitro system for the optimization of ex vivo studies of pancreatic cancer.

Drug Discov Today 2017 04 30;22(4):690-701. Epub 2017 Jan 30.

Bioprocess and Biochemical Engineering Group (BioProChem), Department of Chemical and Process Engineering, University of Surrey, Guildford GU2 7XH, UK. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S13596446173004
Publisher Site
http://dx.doi.org/10.1016/j.drudis.2017.01.012DOI Listing
April 2017

Single-Nucleotide Polymorphism to Associate Cancer Risk.

Methods Mol Biol 2016 ;1381:93-110

NIHR Pancreatic Biomedical Research Unit, Molecular and Clinical Cancer Medicine, Royal Liverpool University Hospital, 5th Floor UCD Block, Daulby Street, Liverpool, L69 3GA, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-4939-3204-7_6DOI Listing
October 2016

Xanthogranulomatous pancreatitis associated with a mucinous cystic neoplam.

Pathol Int 2016 03 12;66(3):174-176. Epub 2015 Nov 12.

National Institute for Health Research Liverpool Pancreas Biomedical Research Unit, Liverpool, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/pin.12356DOI Listing
March 2016

Immunobiological effects of gemcitabine and capecitabine combination chemotherapy in advanced pancreatic ductal adenocarcinoma.

Br J Cancer 2016 Mar 4;114(5):510-8. Epub 2016 Feb 4.

National Institutes of Health Research Liverpool Pancreas Biomedical Research Unit and Clinical Directorate of General Surgery, Royal Liverpool and Broadgreen University Hospitals NHS Trust and the University of Liverpool, Liverpool L69 3GA, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/bjc.2015.468DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4782200PMC
March 2016

Choline Kinase Alpha (CHKα) as a Therapeutic Target in Pancreatic Ductal Adenocarcinoma: Expression, Predictive Value, and Sensitivity to Inhibitors.

Mol Cancer Ther 2016 Feb 14;15(2):323-33. Epub 2016 Jan 14.

Epithelial Carcinogenesis Group, Cancer Cell Biology Programme, Spanish National Cancer Research Center-CNIO, Madrid, Spain. Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-15-0214DOI Listing
February 2016

TERT gene harbors multiple variants associated with pancreatic cancer susceptibility.

Int J Cancer 2015 Nov 19;137(9):2175-83. Epub 2015 Jun 19.

Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.29590DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4548797PMC
November 2015

Inhibition of CD47 Effectively Targets Pancreatic Cancer Stem Cells via Dual Mechanisms.

Clin Cancer Res 2015 May 23;21(10):2325-37. Epub 2015 Feb 23.

Stem Cells and Cancer Group, Molecular Pathology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain. Centre for Stem Cells in Cancer and Ageing, Barts Cancer Institute, A CR-UK Centre of Excellence, Queen Mary University of London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-1399DOI Listing
May 2015

Biomarkers for early diagnosis of pancreatic cancer.

Expert Rev Gastroenterol Hepatol 2015 Mar 6;9(3):305-15. Epub 2014 Nov 6.

Department of Molecular and Clinical Cancer Medicine, National Institute for Health Research Liverpool Pancreas Biomedical Research Unit, University of Liverpool, Daulby Street, Liverpool L69 3GA, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/17474124.2015.965145DOI Listing
March 2015

Incidence of post-ERCP pancreatitis from direct pancreatic juice collection in hereditary pancreatitis and familial pancreatic cancer before and after the introduction of prophylactic pancreatic stents and rectal diclofenac.

Pancreas 2015 Mar;44(2):260-5

From the *National Institute for Health Research Liverpool Pancreas Biomedical Research Unit, Royal Liverpool University Hospital; †Liverpool Clinical Trials Unit; Departments of ‡Gastroenterology, and §Radiology, Royal Liverpool University Hospital, Liverpool; and ║Digestive Diseases Biomedical Research Unit, National Institute for Health Research Nottingham, Queen's Medical Centre, Nottingham, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MPA.0000000000000246DOI Listing
March 2015

Pancreatic mass in a young CFTR carrier with a heterozygous p.R117H CFTR gene mutation and homozygous 7T.

Pancreas 2015 Mar;44(2):343-5

National Institute for Health Research Liverpool Pancreas Biomedical Research Unit Royal Liverpool University Hospital Liverpool, UK Department of Cellular Pathology Royal Liverpool University Hospital Liverpool, UK National Institute for Health Research Liverpool Pancreas Biomedical Research Unit Royal Liverpool University Hospital Liverpool, UK National Institute for Health Research Liverpool Pancreas Biomedical Research Unit Royal Liverpool University Hospital Liverpool, UK

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MPA.0000000000000244DOI Listing
March 2015

Fatty acid ethyl ester synthase inhibition ameliorates ethanol-induced Ca2+-dependent mitochondrial dysfunction and acute pancreatitis.

Gut 2014 Aug 25;63(8):1313-24. Epub 2013 Oct 25.

Department of Cellular & Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool, Merseyside, UK NIHR Liverpool Pancreas Biomedical Research Unit, RLBUHT, Institute of Translational Medicine, University of Liverpool, Liverpool, Merseyside, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/gutjnl-2012-304058DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4112447PMC
August 2014

Serum cytokine biomarker panels for discriminating pancreatic cancer from benign pancreatic disease.

Mol Cancer 2014 May 20;13:114. Epub 2014 May 20.

NIHR Liverpool Pancreas Biomedical Research Unit, Royal Liverpool and Broadgreen University Hospital NHS Trust, Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool L69 3GA, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1476-4598-13-114DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4032456PMC
May 2014

Pancreatic cancer hENT1 expression and survival from gemcitabine in patients from the ESPAC-3 trial.

J Natl Cancer Inst 2014 Jan 3;106(1):djt347. Epub 2013 Dec 3.

Affiliations of authors: Liverpool Cancer Research UK Cancer Trials Unit, Liverpool Cancer Research UK Centre, University of Liverpool, Liverpool, UK (WG, JPN, EG, TFC, PG, EC, CMH, CLR, FC, RJ); the Princess Margaret Hospital, Toronto, Canada (MJM); Manchester Academic Health Sciences Centre, Christie NHS Foundation Trust, School of Cancer and Enabling Sciences, University of Manchester, UK (JWV); Queen Elizabeth Hospital, University Hospital Birmingham NHS Foundation Trust, Birmingham, UK (DHP); Beatson West of Scotland Cancer Centre, Glasgow, UK (ACM); Glasgow Royal Infirmary, Glasgow, UK (RC); Hôpital Tenon, Université, Pierre et Marie Curie, Paris, France (FL); Austin Health, Melbourne, Australia (NCT); Prince of Wales Hospital and Clinical School University of New South Wales, New South Wales, Australia (DG); Nepean Cancer Centre and University of Sydney, Sydney, Australia (JS); Agia Olga Hospital, Athens, Greece (CD); Medical Oncology, Clatterbridge Centre for Oncology, Bebington, Merseyside, UK (DS); Department of Oncology, Akademiska Sjukhuset, Uppsala University, Uppsala, Sweden (BG); University Hospital, North Staffordshire, UK (MD); Freeman Hospital, Newcastle upon Tyne, UK (RMC); Service de Chirurgie Digestive et Viscérale, Hôpital Tenon, Paris, France (FL); Cross Cancer Institute and University of Alberta, Alberta, Canada (JRM, AGS); Churchill Hospital, Oxford University Hospitals NHS Trust, Oxford, UK (MRM); St James's University Hospital, Leeds, UK (AA); Department of Medicine A, University Medicine Greifswald, Greifswald, Germany (JM); Petz Aladar Hospital, Gyor, Hungary (AO); Departments of Surgery and Pathology and ARC-NET Research Center, University of Verona, Italy (AS, CB); Department of Surgery, University of Heidelberg, Heidelberg, Germany (MWB).

View Article

Download full-text PDF

Source
https://academic.oup.com/jnci/article-lookup/doi/10.1093/jnc
Publisher Site
http://dx.doi.org/10.1093/jnci/djt347DOI Listing
January 2014

New biomarkers and targets in pancreatic cancer and their application to treatment.

Nat Rev Gastroenterol Hepatol 2012 Aug 26;9(8):435-44. Epub 2012 Jun 26.

National Institute for Health Research Pancreas Biomedical Research Unit and Liverpool Cancer Research UK Centre, Department of Molecular, University of Liverpool, Liverpool, L69 3GA, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrgastro.2012.119DOI Listing
August 2012

Combination therapy for the treatment of pancreatic cancer.

Anticancer Agents Med Chem 2011 Jun;11(5):418-26

Department of Molecular and Clinical Cancer Medicine, the University of Liverpool, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/187152011795677391DOI Listing
June 2011

Single-nucleotide polymorphism (SNP) analysis to associate cancer risk.

Methods Mol Biol 2010 ;576:171-96

Division of Surgery and Oncology, University of Liverpool, Liverpool, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-59745-545-9_10DOI Listing
January 2010

International registries of families at high risk of pancreatic cancer.

Pancreatology 2008 26;8(6):558-65. Epub 2008 Sep 26.

Division of Surgery, University of Liverpool, Royal Liverpool University Hospital, Liverpool, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000159214DOI Listing
December 2008

New treatment options for advanced pancreatic cancer.

Expert Rev Gastroenterol Hepatol 2008 Oct;2(5):673-96

Royal Surrey County Hospital NHS Trust, Egerton Road, Guildford, GU2 7XX, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/17474124.2.5.673DOI Listing
October 2008

Potentiation of chemotherapeutics by the Hsp90 antagonist geldanamycin requires a steady serum condition.

Mol Carcinog 2007 Jun;46(6):466-75

Division of Gastroenterology, Liverpool University, Liverpool, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mc.20296DOI Listing
June 2007

Evaluation of the 4q32-34 locus in European familial pancreatic cancer.

Cancer Epidemiol Biomarkers Prev 2006 Oct;15(10):1948-55

Division of Surgery and Oncology, University of Liverpool, Liverpool, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-06-0376DOI Listing
October 2006

Increasing survival rates of patients with pancreatic cancer by earlier identification.

Nat Clin Pract Oncol 2006 Jul;3(7):346-7

EUROPAC project, Liverpool, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncponc0483DOI Listing
July 2006

Trypsinogen mutations in pancreatic disorders.

Endocrinol Metab Clin North Am 2006 Jun;35(2):271-87, viii

Division of Surgery and Oncology, The University of Liverpool, 5th Floor UCD Building, Daulby Street, Liverpool, L69 3GA, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ecl.2006.02.006DOI Listing
June 2006

The inherited genetics of pancreatic cancer and prospects for secondary screening.

Best Pract Res Clin Gastroenterol 2006 Apr;20(2):253-83

The University of Liverpool, Division of Surgery and Oncology, 5th Floor UCD, Daulby Street, Liverpool L69 3GA, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bpg.2005.10.007DOI Listing
April 2006

Increased risk of idiopathic chronic pancreatitis in cystic fibrosis carriers.

Hum Mutat 2005 Oct;26(4):303-7

Department of Medicine, Durham Veterans Administration and Duke University Medical Center, Durham, North Carolina 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/humu.20232DOI Listing
October 2005

Cationic trypsinogen mutations and pancreatitis.

Clin Lab Med 2005 Mar;25(1):39-59

Department of Surgery and Oncology, University of Liverpool, 5th Floor, University Clinical Department Building, Daulby Street, Liverpool, L69 3GA, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cll.2004.12.004DOI Listing
March 2005

Cationic trypsinogen mutations and pancreatitis.

Gastroenterol Clin North Am 2004 Dec;33(4):767-87

Department of Surgery, Liverpool University, 5th Floor, University Clinical Department Building, Daulby Street, Liverpool, L69 3GA, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.gtc.2004.07.003DOI Listing
December 2004

No evidence for germline mutations of the LKB1/STK11 gene in familial pancreatic carcinoma.

Cancer Lett 2004 Oct;214(1):63-8

Department of Visceral, Thoracic and Vascular Surgery, University Hospital Carl Gustav Carus, Technical University of Dresden, Fetscherstrasse 74, 01307 Dresden, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2004.06.012DOI Listing
October 2004

5-Fluorouracil or gemcitabine combined with adenoviral-mediated reintroduction of p16INK4A greatly enhanced cytotoxicity in Panc-1 pancreatic adenocarcinoma cells.

J Gene Med 2004 May;6(5):514-25

Department of Surgery, Royal Liverpool University Hospital, 5th Floor, UCD Building, Daulby Street, University of Liverpool, Liverpool, UK.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/jgm.540
Publisher Site
http://dx.doi.org/10.1002/jgm.540DOI Listing
May 2004